2028年臨床試驗成像市場預測 - COVID-19的影響和全球分析,按模式、服務(操作成像服務、成像軟體、閱讀分析服務、試驗設計和諮詢服務及其他)和終端用戶分類
市場調查報告書
商品編碼
1296741

2028年臨床試驗成像市場預測 - COVID-19的影響和全球分析,按模式、服務(操作成像服務、成像軟體、閱讀分析服務、試驗設計和諮詢服務及其他)和終端用戶分類

Clinical Trial Imaging Market Forecast to 2028 - Global Analysis By Modality, Offering (Operational Imaging Services, Imaging Software, Read Analysis Services, Trial Design and Consulting Services, and Others), and End User

出版日期: | 出版商: The Insight Partners | 英文 186 Pages | 訂單完成後即時交付

價格

預計到2028年,臨床試驗成像市場規模將從2022年的16.1億美元達到24.8億美元;估計從2023年到2028年將紀錄7.6%的複合成長率。

提供醫學影像服務的CRO數量激增促進了市場成長

臨床研究組織(CRO)透過使用高品質的設施和深入的主題專業知識提供的服務,協助臨床試驗的成功實施。由於CRO的高效和具有成本效益的運作使試驗申辦者受益,已成為臨床試驗行業的骨幹力量。例如,平均而言,CRO在進行和完成臨床試驗方面比內部活動的時間要少30%。

隨著CRO數量的增加,導致競爭激烈,其中一些企業提供專門的成像服務,因此出現了成像CRO(iCROs)。 Keosys醫學影像公司和Medica Group PLC就是iCROs的例子。自2010年以來,臨床試驗的總數倍增,而在這些試驗中使用的成像方式增加了近500%。根據KEOSYS MEDICAL IMAGING公司的一份報告,iCROs將其預算的7.5-10%用於成像,這有助於最佳化工作流程,管理從圖像採集到解釋的每一步。這些CRO在成像的場地資格、標準化圖像的獲取、讀取設計和標準的確定等方面提供關鍵的知識見解,從而促進了整個臨床試驗成像市場的成長。

市場機會

矽片成像臨床試驗將在未來幾年提供市場機會

根據SPIE 2023年的一份報告,臨床試驗是昂貴而漫長的,這導致了監管評估的延遲,並大幅影響了患者對新型和高品質藥品的獲取。在評估成像技術的安全性和有效性時採用了矽片成像技術,與臨床試驗相比負擔較小,因為提供了最小的誤差。臨床試驗中的模擬成像有助於對整個成像系統/其組成部分(來源、對象、任務、觀察者組成部分等)進行電腦模擬,這有助於研究、開發、最佳化、技術評估和監管評估。

模擬成像試驗對評估新的醫學成像系統非常重要。 2019年3月,監管評估虛擬成像臨床試驗(VICTRE)採用電腦模擬成像,對2986名模擬患者進行了數位乳腺攝影和數位乳房斷層合成術的比較。涵蓋模擬試驗改善了病變檢測性能,對所有乳房大小和病變類型來說都有利於斷層合成。 VICTRE的研究結果顯示,模擬成像試驗和電腦模擬成像工具可能成為成像設備監管評估中可行的證據來源,又為臨床試驗成像市場的成長提供了有利的機會。

2022年,中國占據了亞太地區臨床試驗成像市場的最大佔有率,預計在預測期內的年複合成長率為8.6%。中國市場的成長主要歸功於成熟的製藥市場、製藥和生物製藥公司不斷增加的研發支出、由於成本較低而不斷增加的臨床試驗數量,以及有利的監管政策。中國擁有世界第二大醫藥市場。中國人口過多,加上各種傳染病和非傳染病的流行,是有利於中國製藥公司發展的關鍵因素。

臨床試驗成像市場的主要參與者透過各種策略確保成長。 2022年1月,為臨床試驗提供解決方案的技術公司Clario和放射性藥物生產和正電子發射斷層掃描公司XingImaging擴大了合作關係,在中國提供PET成像臨床試驗,以測試新型治療方法。

國家衛生研究院的臨床研究網路、美國疾病控制和預防中心(CDC)、南澳洲州衛生和醫學研究所、探索性腫瘤學研究和臨床試驗中心以及治療用品管理局(TGA)是在編寫臨床試驗成像市場報告時參考的幾個主要的第一和第二來源。

目錄

第一章:簡介

  • 本研究的範圍
  • Insight Partners的研究報告指南
  • 市場細分
    • 全球臨床試驗成像市場- 按模式分類
    • 全球臨床試驗成像市場- 按產品分類
    • 全球臨床試驗成像市場- 按終端用戶分類
    • 全球臨床試驗成像市場- 按地理區域分類

第二章:臨床試驗成像市場- 主要結論

第三章:研究方法

  • 涵蓋範圍
  • 二級研究
  • 初級研究

第四章:臨床試驗成像市場- 市場格局

  • 市場概況
  • PEST分析
    • 北美洲PEST分析
    • 歐洲PEST分析
    • 亞太地區PEST分析
    • 中東和非洲PEST分析
    • 南美和中美洲PEST分析
  • 專家意見

第五章:臨床試驗成像市場- 主要市場動態

  • 市場驅動力
    • 製藥和生物技術行業的臨床試驗活動加速發展
    • 提供醫學影像服務的CRO數量激增
  • 市場限制因素
    • 高投資和標準化的基礎設施要求
  • 市場機會
    • 線性成像臨床試驗
  • 未來趨勢
    • 人工智慧驅動的臨床試驗
  • 影響分析

第六章:臨床試驗成像市場- 全球分析

  • 全球臨床試驗成像市場收入預測和分析
  • 按地理區域分類的全球臨床試驗成像市場- 預測與分析
  • 主要參與者的市場定位

第七章:2028年臨床試驗成像市場收入和預測- 按模式分類

  • 概述
  • 按模式分類,臨床試驗成像市場收入佔有率(2022年和2028年)
  • 斷層掃描
  • 超音波
  • 正電子發射斷層掃描
  • X-射線
  • 超聲心動圖
  • 磁共振成像
  • 其他

第八章:2028年臨床試驗成像市場收入和預測- 提供服務

  • 概述
  • 臨床試驗成像市場收入佔有率,按服務項目分類(2022年和2028年)
  • 試驗設計諮詢服務
    • 概述
  • 閱讀分析服務
    • 概述
  • 操作成像服務
    • 醫學影像服務簡介
  • 成像軟體
    • 縱覽
  • 其他
    • 概述

第九章:2028年臨床試驗成像市場收入和預測- 按終端用戶分類

  • 概述
  • 臨床試驗成像市場收入佔有率,按終端用戶分類(2022年和2028年)
  • 製藥和生物製藥公司
  • 契約研究組織
  • 學術和研究機構
  • 其他

第十章:臨床試驗成像市場- 2028年的收入和預測- 地域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 亞太其他地區
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美和中美洲其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區

第十一章:COVID-19大流行對臨床試驗成像市場的影響

  • 北美洲:對COVID-19大流行的評估
  • 歐洲
  • 亞太地區
  • 南美洲和中美洲
  • 中東和非洲

第十二章:臨床試驗成像市場- 行業格局

  • 概述
  • 臨床試驗成像市場的成長策略
  • 無機成長戰略
    • 概述
  • 有機成長策略
    • 綜述

第十三章:公司簡介

  • eResearch Technology Inc
  • Calyx Inc
  • ICON PLC
  • VIDA Diagnostics Inc
  • WCG Clinical Inc
  • BioTelemetry Inc
  • Medical Metrics Inc
  • Medpace Holdings Inc
  • Radiant Sage LLC
  • IXICO plc

第十四章:附錄

  • 關於Insight Partners
  • 術語表
Product Code: TIPHE100001201

The clinical trial imaging market size is expected to reach US$ 2.48 billion by 2028 from US$ 1.61 billion in 2022; it is estimated to record a CAGR of 7.6% from 2023 to 2028.

Spur in Number of CROs Offering Medical Imaging Services Bolsters Market Growth

Clinical research organizations (CROs) assist in the successful implementation of clinical trials through the services offered using high-quality facilities and deep subject matter expertise. CROs have become the backbone of the clinical trial industry due to their efficient and cost-effective operations that benefit trial sponsors. For example, on an average, CROs take 30% lesser time than in-house activity to conduct and complete clinical trials.

With the rising number of CROs, leading to high competition, some of these businesses offer specialized imaging services, thus emerging as imaging CROs (iCROs). Keosys Medical Imaging and Medica Group PLC are the examples of iCROs. The total number of clinical trials has doubled since 2010, and the use of imaging modalities in these trials has increased by almost 500%. Per a report by KEOSYS MEDICAL IMAGING company, iCROs allocate 7.5-10% of their budgets for imaging, which helps them optimize their workflow to manage every step of the process, from image acquisition to interpretation. These CROs offer key knowledge insights in areas such as site qualification for imaging, acquisition of standardized images, and determination of read designs and criteria, thereby contributing to the growth of the overall clinical trial imaging market.

Market Opportunity

In-Silico Imaging Clinical Trials to Provide Market Opportunities in Coming Years

According to a 2023 report by the SPIE, clinical trials are expensive and lengthy, which causes delays in regulatory evaluation and significantly affects patients' access to novel and high-quality pharmaceutical products. In-silico imaging is employed in the evaluation of safety and effectiveness of imaging technologies with less burden than clinical trials as they provide minimal errors. In-silico imaging in clinical trials aid in the computer simulation of an entire imaging system/its components (source, object, task, observer components, etc.), which assists in research, development, optimization, technology assessment, and regulatory evaluation.

In-silico imaging trials are vital in evaluating new medical imaging systems. In March 2019, the Virtual Imaging Clinical Trial for Regulatory Evaluation (VICTRE) was conducted using computer-simulated imaging of 2,986 in-silico patients for comparing digital mammography and digital breast tomosynthesis. Incorporating in-silico trials improved lesion detection performance, favoring tomosynthesis for all breast sizes and lesion types. Findings of VICTRE reveal that in-silico imaging trials and computer simulation imaging tools are likely to be viable sources of evidence in the regulatory evaluation of imaging devices, in turn, providing lucrative opportunities for the growth of the clinical trial imaging market.

China held the largest share of the clinical trial imaging market in Asia Pacific in 2022, and it is expected to register a CAGR of 8.6% during the forecast period. The growth of the market in China is primarily attributed to the established pharmaceutical market, increasing R&D expenditures by the pharmaceutical and biopharmaceutical companies, rising number of clinical trials due to lower cost, and favorable regulatory policies. China has the world's second largest pharmaceutical market. The excessive population in China, coupled with the prevalence of various communicable and non-communicable diseases, are the key factors favoring the growth of the pharmaceutical companies in China.

Key players in the clinical trial imaging market secure growth through various strategies. In January 2022, Clario, a technology company that delivers solutions for clinical trials, and XingImaging, a radiopharmaceutical production and positron emission tomography company, expanded their partnership to deliver PET imaging clinical trials for testing novel therapeutics in China.

The National Institute for Health Research's Clinical Research Network, the Centers for Disease Control and Prevention (CDC), South Australian Health and Medical Research Institute, Exploratory Oncology Research & Clinical Trial Center, and Therapeutic Goods Administration (TGA) are a few key primary and secondary sources referred to while preparing the report on the clinical trial imaging market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the clinical trial imaging market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global clinical trial imaging market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Clinical Trial Imaging Market - by Modality
    • 1.3.2 Global Clinical Trial Imaging Market - by Offering
    • 1.3.3 Global Clinical Trial Imaging Market - by End User
    • 1.3.4 Global Clinical Trial Imaging Market - by Geography

2. Clinical Trial Imaging Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Clinical Trial Imaging Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis
    • 4.2.2 Europe PEST Analysis
    • 4.2.3 Asia Pacific PEST Analysis
    • 4.2.4 Middle East and Africa PEST Analysis
    • 4.2.5 South and Central America PEST Analysis
  • 4.3 Expert Opinion

5. Clinical Trial Imaging Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Accelerated Clinical Trial Activities in Pharmaceutical and Biotechnology Industry
    • 5.1.2 Spur in Number of CROs Offering Medical Imaging Services
  • 5.2 Market Restraints
    • 5.2.1 High Investment and Standardized Infrastructure Requirements
  • 5.3 Market Opportunities
    • 5.3.1 In-Silico Imaging Clinical Trials
  • 5.4 Future Trends
    • 5.4.1 AI-Driven Clinical Trials
  • 5.5 Impact Analysis

6. Clinical Trial Imaging Market - Global Analysis

  • 6.1 Global Clinical Trial Imaging Market Revenue Forecast and Analysis
  • 6.2 Global Clinical Trial Imaging Market, by Geography - Forecast and Analysis
  • 6.3 Market Positioning of Key Players

7. Clinical Trial Imaging Market Revenue and Forecast To 2028 - by Modality

  • 7.1 Overview
  • 7.2 Clinical Trial Imaging Market Revenue Share, by Modality (2022 and 2028)
  • 7.3 Tomography
    • 7.3.1 Overview
    • 7.3.2 Tomography: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.4 Ultrasound
    • 7.4.1 Overview
    • 7.4.2 Ultrasound: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.5 Positron Emission Tomography
    • 7.5.1 Overview
    • 7.5.2 PET: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.6 X-Ray
    • 7.6.1 Overview
    • 7.6.2 X-Ray: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.7 Echocardiography
    • 7.7.1 Overview
    • 7.7.2 Echocardiography: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.8 Magnetic Resonance Imaging
    • 7.8.1 Overview
    • 7.8.2 Magnetic Resonance Imaging: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.9 Others
    • 7.9.1 Overview
    • 7.9.2 Others: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)

8. Clinical Trial Imaging Market Revenue and Forecast To 2028 - Offering

  • 8.1 Overview
  • 8.2 Clinical Trial Imaging Market Revenue Share, by Offering (2022 and 2028)
  • 8.3 Trial Design Consulting Services
    • 8.3.1 Overview
    • 8.3.2 Trial Design Consulting Services: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Read Analysis Services
    • 8.4.1 Overview
    • 8.4.2 Read Analysis Services: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.5 Operational Imaging Services
    • 8.5.1 Overview
    • 8.5.2 Operational Imaging Services: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.6 Imaging Software
    • 8.6.1 Overview
    • 8.6.2 Imaging Software: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.7 Others
    • 8.7.1 Overview
    • 8.7.2 Others: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)

9. Clinical Trial Imaging Market Revenue and Forecasts To 2028- by End User

  • 9.1 Overview
  • 9.2 Clinical Trial Imaging Market Revenue Share, by End User (2022 and 2028)
  • 9.3 Pharmaceutical and Biopharmaceutical Companies
    • 9.3.1 Overview
    • 9.3.2 Pharmaceutical and Biopharmaceutical Companies: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Contract Research Organizations
    • 9.4.1 Overview
    • 9.4.2 Contract Research Organizations: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Academic and Research Institutes
    • 9.5.1 Overview
    • 9.5.2 Academic and Research Institutes: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)

10. Clinical Trial Imaging Market - Revenue and Forecast to 2028 - Geographic Analysis

  • 10.1 North America: Clinical Trial Imaging Market
    • 10.1.1 Overview
    • 10.1.2 North America: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
    • 10.1.3 North America: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
    • 10.1.4 North America: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
    • 10.1.5 North America: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
    • 10.1.6 North America: Clinical Trial Imaging Market, by Country, 2022& 2028 (%)
      • 10.1.6.1 US: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.1.1 Overview
        • 10.1.6.1.2 US: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.1.3 US: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
        • 10.1.6.1.4 US: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
        • 10.1.6.1.5 US: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
      • 10.1.6.2 Canada: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.2.1 Overview
        • 10.1.6.2.2 Canada: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.2.3 Canada: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
        • 10.1.6.2.4 Canada: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
        • 10.1.6.2.5 Canada: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
      • 10.1.6.3 Mexico: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.3.1 Overview
        • 10.1.6.3.2 Mexico: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.3.3 Mexico: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
        • 10.1.6.3.4 Mexico: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
        • 10.1.6.3.5 Mexico: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
  • 10.2 Europe: Clinical Trial Imaging Market
    • 10.2.1 Overview
    • 10.2.2 Europe: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
    • 10.2.3 Europe: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
    • 10.2.4 Europe: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
    • 10.2.5 Europe: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
    • 10.2.6 Europe: Clinical Trial Imaging Market, by Country, 2022 & 2028 (%)
      • 10.2.6.1 Germany: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.1.1 Overview
        • 10.2.6.1.2 Germany: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.1.3 Germany: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
        • 10.2.6.1.4 Germany: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
        • 10.2.6.1.5 Germany: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
      • 10.2.6.2 UK: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.2.1 Overview
        • 10.2.6.2.2 UK: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.2.3 UK: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
        • 10.2.6.2.4 UK: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
        • 10.2.6.2.5 UK: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
      • 10.2.6.3 France: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.3.1 Overview
        • 10.2.6.3.2 France: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.3.3 France: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
        • 10.2.6.3.4 France: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
        • 10.2.6.3.5 France: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
      • 10.2.6.4 Italy: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.4.1 Overview
        • 10.2.6.4.2 Italy: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.4.3 Italy: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
        • 10.2.6.4.4 Italy: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
        • 10.2.6.4.5 Italy: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
      • 10.2.6.5 Spain: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.5.1 Overview
        • 10.2.6.5.2 Spain: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.5.3 Spain: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
        • 10.2.6.5.4 Spain: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
        • 10.2.6.5.5 Spain: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
      • 10.2.6.6 Rest of Europe: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.6.1 Overview
        • 10.2.6.6.2 Rest of Europe: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.6.3 Rest of Europe: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
        • 10.2.6.6.4 Rest of Europe: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
        • 10.2.6.6.5 Rest of Europe: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
  • 10.3 Asia Pacific: Clinical Trial Imaging Market
    • 10.3.1 Overview
    • 10.3.2 Asia Pacific: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
    • 10.3.3 Asia Pacific: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
    • 10.3.4 Asia Pacific: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
    • 10.3.5 Asia Pacific: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
    • 10.3.6 Asia Pacific: Clinical Trial Imaging Market, by Country, 2022 & 2028 (%)
      • 10.3.6.1 China: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.1.1 China: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.1.2 China: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
        • 10.3.6.1.3 China: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
        • 10.3.6.1.4 China: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
      • 10.3.6.2 Japan: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.2.1 Japan: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.2.2 Japan: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
        • 10.3.6.2.3 Japan: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
        • 10.3.6.2.4 Japan: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
      • 10.3.6.3 India: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.3.1 India: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.3.2 India: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
        • 10.3.6.3.3 India: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
        • 10.3.6.3.4 India: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
      • 10.3.6.4 South Korea: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.4.1 South Korea: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.4.2 South Korea: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
        • 10.3.6.4.3 South Korea: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
        • 10.3.6.4.4 South Korea: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
      • 10.3.6.5 Australia: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.5.1 Australia: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.5.2 Australia: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
        • 10.3.6.5.3 Australia: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
        • 10.3.6.5.4 Australia: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
      • 10.3.6.6 Rest of Asia Pacific: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.6.1 Rest of Asia Pacific: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.6.2 Rest of Asia Pacific: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
        • 10.3.6.6.3 Rest of Asia Pacific: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
        • 10.3.6.6.4 Rest of Asia Pacific: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
  • 10.4 South and Central America: Clinical Trial Imaging Market
    • 10.4.1 Overview
    • 10.4.2 South and Central America: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
    • 10.4.3 South and Central America: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
    • 10.4.4 South and Central America: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
    • 10.4.5 South and Central America: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
      • 10.4.5.1 Brazil: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.5.1.1 Brazil: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.5.1.2 Brazil: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
        • 10.4.5.1.3 Brazil: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
        • 10.4.5.1.4 Brazil: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
      • 10.4.5.2 Argentina: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.5.2.1 Argentina: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.5.2.2 Argentina: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
        • 10.4.5.2.3 Argentina: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
        • 10.4.5.2.4 Argentina: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
      • 10.4.5.3 Rest of South and Central America: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.5.3.1 Rest of South and Central America: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.5.3.2 Rest of South and Central America: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
        • 10.4.5.3.3 Rest of South and Central America: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
        • 10.4.5.3.4 Rest of South and Central America: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
  • 10.5 Middle East & Africa Clinical Trial Imaging Market
    • 10.5.1 Overview
    • 10.5.2 Middle East & Africa: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
    • 10.5.3 Middle East & Africa: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
    • 10.5.4 Middle East & Africa: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
    • 10.5.5 Middle East & Africa Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
    • 10.5.6 Middle East & Africa: Clinical Trial Imaging Market, by Country, 2022 & 2028 (%)
      • 10.5.6.1 South Africa: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.1.1 Overview
        • 10.5.6.1.2 South Africa: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.1.3 South Africa: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
        • 10.5.6.1.4 South Africa: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
        • 10.5.6.1.5 South Africa Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
      • 10.5.6.2 Saudi Arabia: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.2.1 Overview
        • 10.5.6.2.2 Saudi Arabia: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.2.3 Saudi Arabia: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
        • 10.5.6.2.4 Saudi Arabia: Clinical Trial Imaging Market, by Product and Services, 2020-2028 (US$ Million)
        • 10.5.6.2.5 Saudi Arabia Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
      • 10.5.6.3 UAE: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.3.1 Overview
        • 10.5.6.3.2 UAE: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.3.3 UAE: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
        • 10.5.6.3.4 UAE: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
        • 10.5.6.3.5 UAE Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
      • 10.5.6.4 Rest of Middle East & Africa: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.4.1 Overview
        • 10.5.6.4.2 Rest of Middle East & Africa: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.4.3 Rest of Middle East & Africa: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
        • 10.5.6.4.4 Rest of Middle East & Africa: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
        • 10.5.6.4.5 Rest of Middle East & Africa Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)

11. Impact Of COVID-19 Pandemic on Clinical Trial Imaging Market

  • 11.1 North America: Assessment of COVID-19 Pandemic
  • 11.2 Europe: Impact Assessment of COVID-19 Pandemic
  • 11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
  • 11.4 South and Central America: Impact Assessment of COVID-19 Pandemic
  • 11.5 Middle East and Africa: Impact Assessment of COVID-19 Pandemic

12. Clinical Trial Imaging Market - Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in Clinical Trial Imaging Market
  • 12.3 Inorganic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Organic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 eResearch Technology Inc
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Calyx Inc
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 ICON PLC
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 VIDA Diagnostics Inc
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 WCG Clinical Inc
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 BioTelemetry Inc
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Medical Metrics Inc
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Medpace Holdings Inc
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Radiant Sage LLC
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 IXICO plc
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms

List Of Tables

  • Table 1. North America Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 2. North America Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
  • Table 3. North America Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 4. US Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 5. US Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
  • Table 6. US Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 7. Canada: Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 8. Canada: Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
  • Table 9. Canada: Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 10. Mexico: Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 11. Mexico: Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
  • Table 12. Mexico: Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 13. Europe Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 14. Europe Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
  • Table 15. Europe Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 16. Germany: Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 17. Germany: Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
  • Table 18. Germany: Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 19. UK Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 20. UK Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
  • Table 21. UK Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 22. France: Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 23. France: Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
  • Table 24. France: Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 25. Italy: Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 26. Italy: Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
  • Table 27. Italy: Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 28. Spain: Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 29. Spain: Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
  • Table 30. Spain: Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 31. Rest of Europe: Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 32. Rest of Europe: Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
  • Table 33. Rest of Europe: Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 34. Asia Pacific Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
  • Table 35. Asia Pacific Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
  • Table 36. Asia Pacific Clinical Trial Imaging Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 37. China Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
  • Table 38. China Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
  • Table 39. China Clinical Trial Imaging Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 40. Japan Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
  • Table 41. Japan Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
  • Table 42. Japan Clinical Trial Imaging Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 43. India Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
  • Table 44. India Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
  • Table 45. India Clinical Trial Imaging Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 46. South Korea Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
  • Table 47. South Korea Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
  • Table 48. South Korea Clinical Trial Imaging Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 49. Australia Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
  • Table 50. Australia Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
  • Table 51. Australia Clinical Trial Imaging Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 52. Rest of Asia Pacific Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
  • Table 53. Rest of Asia Pacific Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
  • Table 54. Rest of Asia Pacific Clinical Trial Imaging Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 55. South and Central America Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
  • Table 56. South and Central America Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
  • Table 57. South and Central America Clinical Trial Imaging Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 58. Brazil Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
  • Table 59. Brazil Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
  • Table 60. Brazil Clinical Trial Imaging Market, by End Use- Revenue and Forecast to 2028 (US$ Million)
  • Table 61. Argentina Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
  • Table 62. Argentina Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
  • Table 63. Argentina Clinical Trial Imaging Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 64. Rest of South and Central America Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
  • Table 65. Rest of South and Central America Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
  • Table 66. Rest of South and Central America Clinical Trial Imaging Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 67. Middle East & Africa Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 68. Middle East & Africa Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
  • Table 69. Middle East & Africa Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 70. South Africa Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 71. South Africa Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
  • Table 72. South Africa Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 73. Saudi Arabia Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 74. Saudi Arabia Clinical Trial Imaging Market, by Product and Services - Revenue and Forecast to 2028 (US$ Million)
  • Table 75. Saudi Arabia Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 76. UAE Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 77. UAE Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
  • Table 78. UAE Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 79. Rest of Middle East & Africa Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 80. Rest of Middle East & Africa Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
  • Table 81. Rest of Middle East & Africa Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 82. Recent Inorganic Growth Strategies in the Clinical Trial Imaging Market
  • Table 83. Recent Organic Growth Strategies in Clinical Trial Imaging Market
  • Table 84. Glossary of Terms

List Of Figures

  • Figure 1. Clinical Trial Imaging Market Segmentation
  • Figure 2. Clinical Trial Imaging Market by Region
  • Figure 3. Global Clinical Trial Imaging Market Overview
  • Figure 4. Tomography Largest Share of Modality Segment in Clinical Trial Imaging Market
  • Figure 5. Asia Pacific Expected to Show Remarkable Growth During Forecast Period
  • Figure 6. Clinical Trial Imaging Market, by Geography (US$ Million)
  • Figure 7. Global Clinical Trial Imaging Market - Leading Country Markets (US$ Million)
  • Figure 8. Global Clinical Trial Imaging Market - Industry Landscape
  • Figure 9. North America: PEST Analysis
  • Figure 10. Europe: PEST Analysis
  • Figure 11. Asia Pacific: PEST Analysis
  • Figure 12. Middle East and Africa: PEST Analysis
  • Figure 13. South and Central America: PEST Analysis
  • Figure 14. Clinical Trial Imaging Market: Impact Analysis of Drivers and Restraints
  • Figure 15. Global Clinical Trial Imaging Market - Revenue Forecast and Analysis - 2021-2028
  • Figure 16. Global Clinical Trial Imaging Market, by Geography - Forecast and Analysis (2022-2028)
  • Figure 17. Market Positioning of Key Players in the Clinical Trial Imaging Market
  • Figure 18. Clinical Trial Imaging Market Revenue Share, by Modality (2022 and 2028)
  • Figure 19. Tomography: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 20. Ultrasound: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 21. PET: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 22. X-Ray: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 23. Echocardiography: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 24. Magnetic Resonance Imaging: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 25. Others: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 26. Clinical Trial Imaging Market Revenue Share, by Offering (2022 and 2028)
  • Figure 27. Trial Design Consulting Services: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 28. Read Analysis Services: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 29. Operational Imaging Services: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 30. Imaging Software: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 31. Others: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 32. Clinical Trial Imaging Market Revenue Share, by End User (2022 and 2028)
  • Figure 33. Pharmaceutical and Biopharmaceutical Companies: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 34. Contract Research Organizations: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 35. Academic and Research Institutes: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 36. Others: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 37. North America: Clinical Trial Imaging Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 38. North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 39. North America: Clinical Trial Imaging Market, by Country, 2022 & 2028 (%)
  • Figure 40. US: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 41. Canada: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 42. Mexico: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 43. Europe: Clinical Trial Imaging Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 44. Europe Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 45. Europe: Clinical Trial Imaging Market, by Country, 2022 & 2028 (%)
  • Figure 46. Germany: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 47. UK: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 48. France: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 49. Italy: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 50. Spain: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 51. Rest of Europe: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 52. Asia Pacific: Clinical Trial Imaging Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 53. Asia Pacific Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 54. China Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 55. Japan Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 56. India Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 57. South Korea Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 58. Australia Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 59. Rest of Asia Pacific Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 60. South and Central America: Clinical Trial Imaging Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 61. South and Central America Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 62. Brazil Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 63. Argentina Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 64. Rest of South and Central America Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 65. Middle East & Africa: Clinical Trial Imaging Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 66. Middle East & Africa Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 67. South Africa: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 68. Saudi Arabia: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 69. UAE: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 70. Rest of Middle East & Africa: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 71. Impact of COVID-19 Pandemic on North American Country Markets
  • Figure 72. Impact of COVID-19 Pandemic on European Country Markets
  • Figure 73. Impact of COVID-19 Pandemic In Asia Pacific Country Markets
  • Figure 74. Impact of COVID-19 Pandemic on South and Central America Country Markets
  • Figure 75. Impact of COVID-19 Pandemic on Middle East and Africa Country Markets
  • Figure 76. Growth Strategies in Clinical Trial Imaging Market